ʻO Rituximab a me Hyaluronidase Inikua Kanaka

Anter

• Ma mua o ka loaʻa ʻana o ka rituximab a me ka hyaluronidase injection kanaka,
• ʻO Rituximab a me hyaluronidase kanaka injection paha ke kumu i nā hopena ʻaoʻao.E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

Ua hoʻokumu ʻo Rituximab a me hyaluronidase i ke kūpilikiʻi kanaka i koʻikoʻi, ola i ka ʻili a me ka waha. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e haʻi koke aku i kāu kauka: ʻehaʻeha a ʻeha paha ma ka ʻili, lehelehe, a waha paha; pāhaʻa; ʻehu; a i ʻole ka ʻili peeling.

Ua hele a maʻi paha ʻoe i ka maʻi hepatitis B (kahi maʻi i hoʻopili ʻia i ke akepaʻa a e hōʻeha paha i ka ate) akā ʻaʻohe o nā ʻōuli o ka maʻi. I kēia hihia, ʻo ka loaʻa ʻana o ka rituximab a me ka hyaluronidase injection kanaka e hoʻonui paha i ka makaʻu e lilo i kou maʻi a ʻoi aku ka weliweli a e hoʻomohala ʻoe i nā ʻōuli. E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe i kahi maʻi ʻino, e like me ka maʻi maʻi virus hepatitis B. E kauoha aku kāu kauka i kahi hoʻokolohua koko e ʻike inā loaʻa iā ʻoe kahi maʻi hepatitis B hana ʻole. Inā pono, hiki i kāu kauka ke hāʻawi iā ʻoe i lāʻau e mālama ai i kēia maʻi ma mua a i kou wā e mālama ai me ka rituximab a me ka hyaluronidase injection kanaka. E nānā pū kāu kauka iā ʻoe no nā hōʻailona o ka maʻi hepatitis B i ka manawa a no kekahi mau mahina ma hope o kāu lapaʻau. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope a i ʻole a ma hope paha o kāu lapaʻau ʻana, e kāhea koke aku i kāu kauka: luhi nui, melemele o ka ʻili a i ʻole nā ​​maka, nalo ʻole ka makemake, kahoʻi a i ʻole ka luaʻi, ʻeha ka ʻeha, ʻeha o ka ʻōpū, a me ka mimi ʻeleʻele.

ʻO kekahi poʻe i loaʻa i ka rituximab a me ka hyaluronidase injection kanaka i hoʻomohala i ka leukoencephalopathy multifocal holomua (PML; kahi maʻi laha ʻole o ka lolo i hiki ʻole ke mālama ʻia, pale ʻia, a hoʻōla ʻia a ʻo ka mea maʻamau ka make a i ʻole ke kīnā koʻikoʻi) i ka wā a ma hope paha o kā lākou lapaʻau ʻana. Inā ʻoe e ʻike i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka: nā loli hou a i ʻole hikiwawe i ka noʻonoʻo a huikau paha; paʻakikī i ke kamaʻilio ʻana a i ʻole ka hele wāwae ʻana; nalo o ke kaulike; lilo o ka ikaika; nā hoʻololi hou a hiwahiwa paha i ka hihiʻo; a i ʻole nā ​​hōʻailona ʻē aʻe e hoʻomohala koke.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua lab e nānā i ka pane o kou kino i ka rituximab a me ka hyaluronidase kanaka injection.

E hāʻawi aku kāu kauka a kauka paha iā ʻoe i ka palapala ʻike hoʻomanawanui a ka mea hana (Ke alakaʻi alakaʻi) ke hoʻomaka ʻoe i ka lāʻau me ka inikua rituximab a i kēlā me kēia manawa ke loaʻa iā ʻoe ka lāʻau. E heluhelu pono i ka ʻike a nīnau i kāu kauka a kauka paha inā he nīnau kāu. Hiki iā ʻoe ke kipa aku i ka pūnaewele ʻo Food and Drug Administration (FDA) (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) a i ʻole pūnaewele o ka mea hana e kiʻi i ka Medication Guide.

E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka hoʻohana ʻana i ka rituximab a me ka hyaluronidase injection kanaka.

Hoʻohana hoʻokahi ʻia ʻo Rituximab a me hyaluronidase a i ʻole me nā lāʻau ʻē aʻe e mālama ai i nā ʻano lymphoma non-Hodgkin (NHL; kahi ʻano maʻi ʻaʻai e hoʻomaka i kahi ʻano o nā hunaola keokeo e hakakā maʻamau i ka maʻi). Hoʻohana pū ʻia ʻo Rituximab a me hyaluronidase injection me nā lāʻau ʻē aʻe e mālama i ka leukemia lymphocytic mau (CLL; kahi ʻano maʻi ʻaʻai o nā hunaola keʻokeʻo). ʻO Rituximab a me hyaluronidase kanaka injection i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Mālama ia i nā ʻano like ʻole o NHL a me CLL ma ka luku ʻana i nā hunaola maʻi ʻaʻai.

ʻO Rituximab a me hyaluronidase injection ke kanaka e hele mai ma ke ʻano he wai (wai) e ʻoki ʻia subcutaneously (ma lalo o ka ʻili, ma kahi o ka ʻōpū) ma kahi o 5 a 7 mau minuke. E hilinaʻi kāu papa hana ma muli o ke ʻano o kāu, nā lāʻau ʻē aʻe āu e hoʻohana nei, a me ka maikaʻi o ka pane ʻana o kou kino i ka lāʻau.

Hiki i ka Rituximab a me ka hyaluronidase injection ke hana i nā hopena koʻikoʻi ke loaʻa ʻoe i ka lāʻau a i ʻole 24 mau hola ma hope o ka loaʻa ʻana o kahi lāʻau. E loaʻa iā ʻoe kēlā me kēia mahele lāʻau o rituximab a me hyaluronidase injection kanaka i loko o kahi keʻena lapaʻau, a e nānā pono ke kauka a kahu hānai paha iā ʻoe ke loaʻa nei nā lāʻau a ma ka liʻiliʻi he 15 mau minuke ma hope o kou loaʻa ʻana o ka lāʻau. E loaʻa iā ʻoe kekahi mau lāʻau e kōkua ai i ka pale ʻana i kahi hopena maʻi ma mua o kou loaʻa ʻana i kēlā me kēia lāʻau o rituximab a me hyaluronidase kanaka injection.

Pono ʻoe e loaʻa i kāu mahele lāʻau mua ma ke ʻano he huahana inikua rituximab injected intravenously (i loko o kahi aa koko). Ma hope o ka mahele lāʻau mua, loaʻa iā ʻoe ka rituximab a me ka hyaluronidase injection kanaka ma lalo o ka ʻili, kaukaʻi ʻia i ke ʻano o kāu pane ʻana i ka mālama intravenous me kahi huahana injection rituximab.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka loaʻa ʻana o ka rituximab a me ka hyaluronidase injection kanaka,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka rituximab, hyaluronidase, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka rituximab a me ka hyaluronidase injection kanaka. E noi i kāu kauka lāʻau a nānā i ke alakaʻi lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, nā mea hoʻopihaʻai, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe
• e haʻi i kāu kauka inā loaʻa iā ʻoe kekahi o nā ʻano i ʻōlelo ʻia i ka ʻARlelo Aʻo IMPORTANT a inā ua loaʻa iā ʻoe a i ʻole he hepatitis C a i ʻole nā ​​mea ʻino ʻē aʻe e like me ka moa pox, herpes wahi), shingles, West Nile virus (kahi maʻi i pālahalaha ʻia ma waena o nā nahu makika a hiki ke hana i nā ʻōuli koʻikoʻi), parvovirus B19 (maʻi ʻelima; kahi maʻi maʻamau i nā keiki e hana maʻamau i nā pilikia koʻikoʻi i kekahi mau mākua), a i ʻole cytomegalovirus (a ʻo ka maʻi maʻamau ka mea maʻa mau i nā hōʻailona koʻikoʻi i ka poʻe i nāwaliwali i nā ʻōnaehana pale a i ʻole nā ​​mea i loaʻa i ka wā hānau), kahi puʻuwai puʻuwai ʻole, ʻehaʻeha o ka umauma, nā pilikia puʻuwai ʻē aʻe, a me nā pilikia puʻupuʻu a me nā puʻupaʻa. E haʻi aku i kāu kauka inā loaʻa kekahi ʻano maʻi i kēia manawa a i ʻole inā he maʻi paha kāu e hele ʻole a i ʻole kahi maʻi e hele a hele.
• e haʻi i kāu kauka inā hāpai ʻoe a inā ʻoe e hoʻolālā e hāpai. Pono ʻoe e hoʻohana i ka kaohi hānau e pale ai i ka hāpai ʻana i ka wā o kāu mālama ʻana me rituximab a me hyaluronidase injection kanaka a no 12 mau mahina ma hope o kāu hopena hope loa E kamaʻilio me kāu kauka e pili ana i nā ʻano o ka kaohi hānau e holo pono nāu. Inā hāpai ʻoe i ka hoʻohana ʻana i ka rituximab a me ka hyaluronidase injection kanaka, e kāhea i kāu kauka. Hiki paha iā Rituximab ke hōʻeha i ka fetus.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū. ʻAʻole pono ʻoe e hānai i ka wā o kāu mālama ʻana me rituximab a me hyaluronidase injection kanaka a no 6 mau mahina ma hope o kāu hopena hope loa.
• e nīnau i kāu kauka inā pono ʻoe e loaʻa i nā lāʻau āpau ma mua o kou hoʻomaka ʻana i kāu lāʻau me rituximab a me hyaluronidase kanaka injection. ʻAʻohe o nā lāʻau lapaʻau i ka wā o kāu mālama ʻana me ke kamaʻilio ʻole ʻana me kāu kauka.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inā haʻalele ʻoe i kahi manawa e loaʻa ai ka rituximab a me ka hyaluronidase injection kanaka, e kelepona koke i kāu kauka.

ʻO Rituximab a me hyaluronidase kanaka injection paha ke kumu i nā hopena ʻaoʻao.E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• kōpaʻa
• ʻōhinu
• poho lauoho
• ʻeha, huhū, puhū, ʻulaʻula a i ʻole ʻili ma kahi i hāʻawi ʻia ai ka ʻume
• Muscle, ami, a ʻeha hoʻi

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo Aʻo IMPORTANT, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• hives, ʻāwīwī, ʻili, pehu o nā lehelehe, alelo, a puʻu paha, ka liʻiliʻi o ka hanu, paʻakikī ka hanu ʻana a me ka ale ʻana
• ʻūhā
• paupauaho a maʻule paha
• nāwaliwali
• pāhoehoe
• nele i ka ikaika
• ʻeha ka umauma
• kuʻi a i ʻole kuʻi puʻuwai puʻuwai
• ʻeha ka ʻāʻī, ke kuni, ka haʻalulu, ka ʻū, ka pepeiao pepeiao, ʻeha poʻo, a i ʻole nā ​​hōʻailona ʻē aʻe o ka maʻi
• nā kī keʻokeʻo ma ka ʻāʻī a i ʻole ka waha
• paʻakikī, ʻeha, a i ʻole ka urino pinepine
• ʻulaʻula, palupalu, pehu a mehana o kahi ʻili

Hoʻokumu paha ʻo Rituximab a me hyaluronidase i nā hopena ʻē aʻe i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka hoʻohana ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Rituxan Hycela^®